CB Scientific (CBSC) Develops Cannabinoid Delivery

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
125
CB Scientific (CBSC) Develops Cannabinoid Delivery Technologies: CannaRAPID(TM), CannaNASAL(TM) & CannaDERME(TM) for Precise & Controlled Release of Cannabinoid Compounds to Various Patient Groups

DENVER, CO--(Marketwired - Apr 17, 2017) - CB Scientific, Inc. ( OTC PINK : CBSC ), a designer, developer and manufacturer of Cannabis Analytical Tools and Devices, Cannabis Medical Delivery Systems and Personal Analytical Kits and Devices, announces today that the Company has developed a novel product medical device portfolio since acquiring Marutronics Medical Devices in February 2017. The company has developed three core platform technologies; CannaRAPID™, CannaNASAL™, and CannaDERME™, focused on precise dosing and controlled release of cannabinoid compounds for patients. Furthermore, CB Scientific has developed Pain-Patch™ using CannaDERME transdermal delivery and state-of-the art smart device technologies for relieving various kinds of pains. CB Scientific is gearing up for conducting clinical studies using Pain-Patch for various indications. CB Scientific's will be Releasing 1st Gen Pain-Patch™, a Thermo-Responsive Cannabinoid Delivery Device for Targeted Delivery to Brain in second or third quarter 2017.

Further, CB Scientific brings safe, quick and easy to determine results to you through our fast detection kits. CB Scientific is also releasing a 4th generation Test4Kits, a fast cannabinoid detection kit, with a much more user-friendly and faster detection time.

MEDICAL AND DELIVERY DEVICE TECHNOLOGIES AND PRODUCTS:

The cannabinoid compounds works through CB1 and CB2 receptors in our body which is involved with a variety of physiological processes, including mood, pain, appetite, memory and cognitive function. CB1 is mainly aggregated in the brain, delivering some of these key functions.

A major problem in the medical use of cannabinoids is the targeted and efficient delivery of cannabinoid compounds to neural tissues. Oral ingestion can cause the production of unwanted metabolites from cannabinoid compounds by liver and gut microbiota metabolism reducing the effective dose and creating unwanted side-effects. Further, sustained action of cannabinoid may not be possible by oral ingestion. There is a pressing need for precise dosing and targeted delivery of cannabinoids to brain by passing the first-pass liver metabolism. This is resolved through use of transdermal and other innovative methods.

CB Scientific's novel pipeline of technologies and products includes, transdermal, sublingual, and nasal delivery technologies for precise and controlled dosing of cannabinoids. CannaRAPID™ is our proprietary sublingual delivery technologies using orally disintegrating tablet technology. CannaNASAL™ is a nasal delivery technology using liposomal nanoparticles and CannaDERME™ is our transdermal technology using nano-emulsion for fast absorption of cannabinoid compounds. The technologies and formulations of these technologies are completed and medical device products based on these core-technologies are being developed.

" One of the major issue in cannabis use for medical purpose is the precise dosing and delivery technology. As a scientific team, we are taking on that challenge; with our in-house engineering and cannabis science expertise, we have developed various delivery and device technologies which will have far-reaching impact on how to effectively deliver precise dose of cannabis compounds to the patients, " said Bobban Subhadra, M.S., Ph.D, Chief Operating Officer of CB Scientific. " Pain-patch, which is a transdermal device for targeted delivery of cannabinoids, is the result of that commitment, " he added.

Pain-Patch™

CB Scientific has developed Pain-Patch using a combination of CannaDERME transdermal delivery and state-of-the art smart device technology for relieving various kinds of pain symptoms. CB Scientific has formulated cannabidiol-based Pain-Patch for proof-of-concept studies. Highlights include:

  • Cannabidiol is one of the key cannabinoid constituents in Hemp Plant. CBD is non-psychoactive and safe compound with a wide range of therapeutic applications, including the treatment of neural disorders and clinical studies have suggested a wide range of possible therapeutic effects of cannabidiol on several conditions.
  • The Pain-Patch has transcutaneous cannabinoid penetration technology coupled with thermosensitive nano-emulsion for sustained release of compounds for longer time. The device delivers therapeutic doses to brain via brain stem for whole-body effect.
  • The goal of these patches are to produce a pain-patch with a small footprint for easy concealment, a strong formula to counteract the decreased quality of life for individuals who suffer with systemic pain, a long shelf-life and the use of non-toxic and non-abrasive components to create the most comfortable and effective patch on the market using this technology.
  • CB Scientific is gearing up for conducting clinical studies using Pain-Patch for various indications such as stress and anxiety relief, cognitive focus, various kinds of pain, migraines etc.

DIAGNOSTIC TECHNOLOGIES AND PRODUCTS

CB Scientific is also expanding its portfolio of diagnostics and testing technologies by improving existing products and release of new products. CB Scientific has developed and marketed Test 4 kits Technology using a novel approach to rapidly detect THC, CBD and other cannabinoids from a variety of samples. Launched in 2015, our first generation Test4 kits has been well received worldwide.

Using unique detection chemistry, CB Scientific brings safe, quick and easy to determine results to you through our detection kits. We are now in the process of completing development of the 4th generation Test4Kits with a much more user-friendly and faster detection time. Further, CB Scientific has developed and marketed UPrep™, a cannabinoid sampling technology for cannabinoids testing market.

" Excellent feedback from our existing customers have prompted us to come-up with a redesigned, simpler, more user-friendly version, " said John Verghese, Chief Technology Officer of CB Scientific. " We want to expand the market of our next generation Test4 kits to health care, education and law enforcement sectors, " he added.

About CB Scientific, Inc.

CB Scientific ( www.cbscientific.com ), through its subsidiaries, designs, develops and manufactures Life Science Analytical Tools and Devices, Medical Delivery Systems, laboratory services, personal analytical kits and devices and CBD hemp oil and nutraceutical formulations for growers, care takers, dispensaries and companies worldwide. CB Scientific is continuing to develop new technologies specifically for cannabis (hemp) analytics. CB Scientific believes every product sold to patients as "Medical Quality" should be inspected for health benefits, safety, consistency, purity, potency and packaged properly for distribution. CB Scientific has worked with many of the cannabis industry leaders in the country and have also been featured in cannabis industry publications including High Times Magazine, Culture and many trade publications, on-air interviews and panel discussions across the United States. CB Scientific's focus has been the education and safety of consumers combined with innovation to put power into the hands of the patients.

To request further information about CB Scientific, please email us at info@cbscientific.com , log onto our website at http://www.cbscientific.com or visit us on Twitter @cbscientific and Facebook at cbscientificinc.

Forward-Looking Statements

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact: Media Contact CB Scientific Inc. Http://www.cbscientific.com info@cbscientific.com (720) 370-3554 Twitter - @cbscientific Facebook - cbscientificinc

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Veterans Find a Haven in Home Helpers® Franchise

Updated Category News Views 70

Veterans Thriving at Home Helpers® Tossing out a warm welcome to fresh horizons post-military, Home Helpers® Home Care is serving up more than just compassionate care—it’s become a bonafide haven for veterans diving into the world of franchising. This isn’t just an indie pat on the back; according to the latest scoop from Franchise Business Review, Home Helpers®...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 71

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Charlotte's Top-Tier Home Sales Surge: A $15M Milestone

Updated Category News Views 86

Charlotte's Luxury Market: A Rapid Ascent Folks, buckle up, because the luxury home market in Charlotte isn't just on the rise—it's practically sky-high. Back in 2016, the idea of splashing out over $5 million on a house was almost unheard of in this neck of the woods. Only one brave soul did it at the time. Fast forward to this past year, and things are looking starkly...

Continue Reading
Tigo Energy Faces Lawsuit: Key Details for Investors

Updated Category News Views 89

Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...

Continue Reading
Ainstein Expands Kansas Operations Amid Sensor Demand Surge

Updated Category News Views 70

Ainstein's Expansion Conquers New Heights in Radar Tech Ainstein just cranked open a whole new chapter right in the heart of Kansas. And believe me, it's not your average ribbon-cutting story. This shiny new facility in Lenexa is locked and loaded to roll out 44,000 radar sensors a year. It's part of a no-nonsense plan to keep up with soaring demand for their tech across...

Continue Reading
WirelessCar Rebrands to Reinforce Connected Mobility Vision

Updated Category News Views 122

Evolving Identity for Changing Times Let’s dive right into it—WirelessCar, a name that’s struck chords in the automotive trenches for ages, is taking a bold step by unveiling a new brand identity. Now, don’t roll your eyes just yet. This isn’t another company tapping the rebranding siren for the heck of it. We’re talking about a company that’s been in the...

Continue Reading
Investors, Portillo's Fraud Claims Demand Your Attention

Updated Category News Views 0

Portillo's Investors Caught in a Tough Spot Ah, Portillo's. You thought those hot dogs were the only spicy thing you're biting into? Try these allegations on for size. Investors are biting back with a securities fraud lawsuit, and the details are saltier than a bucket of fries. The folks who held PTLO shares between September 19, 2023, and May 4, 2026, are in the...

Continue Reading
Better Life Science: Revolutionizing At-Home STI Testing

Updated Category News Views 115

Paving a New Path for STI Testing Accessibility The landscape of STI testing is undergoing a significant shift, and Better Life Science is at the helm with their innovative STD Hero at-home testing service. With a splash in the latest AVN report, they're turning heads in both the clinical world and in mainstream society. This ain't just about checking boxes in health...

Continue Reading
RBC Grabs Top Honors for Sustainable Investing Leadership

Updated Category News Views 107

A New Feather in RBC's Cap RBC Wealth Management has racked up more accolades, crowned as the Best Private Bank in Canada and celebrated for its prowess in impact and sustainable investing on the global stage. These distinctions flew in courtesy of the PWM Global Private Banking Awards—a heavyweight recognition in the wealth management world. Award Winning Strategy in...

Continue Reading
Choate's Expands to New Mid-South Markets

Updated Category News Views 65

Family Traditions Drive Choate's Growth Back in the day, you might've thought the family-run businesses were a dying breed, right? Not in the case of Choate's Air Conditioning, Heating, Plumbing & Electrical. These folks aren't just holding the fort; they're storming new territories across the Mid-South like they've got something to prove—or maybe just something to...

Continue Reading

Top 5 Most Recently Viewed Articles

Ethan Allen Launches Stylish Design Center in Colorado Springs

Updated Category News Views 229

Introducing the New Ethan Allen Design Center Ethan Allen has proudly opened its latest Design Center in Colorado Springs, situated in the vibrant University Village Shopping Center. This newly constructed space features a beautiful gallery showroom, along with workspaces designed for collaboration between designers and clients. This new center is the fourth for Ethan...

Continue Reading
Understanding Ark Invest's Strategic Moves with AI Leaders

Updated Category News Views 349

Ark Invest's Bold Moves in the AI Sector Cathie Wood, the impactful leader of Ark Invest, continues to make headlines with her investment decisions. Recently, Ark made some noteworthy trades involving Baidu Inc. (NASDAQ: BIDU), Alibaba Group Holding Ltd. (NYSE: BABA), and Brera Holdings PLC (NASDAQ: BREA). These investments spotlight Ark's belief in companies championing...

Continue Reading
Broadcom's Future: Analyst Ratings Fuel Optimism for 2026

Updated Category News Views 287

Broadcom's Impressive Rally and Analysts' Confidence Recently, semiconductor giant Broadcom saw a remarkable rebound, achieving a staggering total return of 51%. This performance stands in sharp contrast to the previous year's underwhelming conclusion. Investors have taken a keen interest in the company, especially as it consistently outpaces the S&P 500’s return, which...

Continue Reading
Novavax's Earnings Preview: What Investors Should Expect

Updated Category News Views 160

Key Insights Before Novavax's Earnings Report Novavax (NASDAQ: NVAX) is set to announce its quarterly earnings soon, and anticipation is building among investors. This overview highlights essential factors for those interested in the upcoming earnings report. Expected Earnings Performance Analysts predict that Novavax will report an earnings per share (EPS) of...

Continue Reading
Bank7 Corp. Reports Impressive Q3 2024 Earnings Results

Updated Category News Views 130

Bank7 Corp. Achieves Record Earnings for Q3 2024 Bank7 Corp. (NASDAQ: BSVN), the parent company of Bank7, has announced outstanding financial results for the third quarter of 2024. In a recent statement, President and CEO Thomas L. Travis remarked, "We are pleased to announce another record quarter of net income and EPS. Our properly matched balance sheet, disciplined...

Continue Reading